Growth in sales of slimming drugs in Russia has slowed: in the third quarter, pharmacy sales of semaglutide increased by 38% compared to a year, and tripled in 2025, - "Kommersant" In January-September 2026, pharmacies sold 6.3 million packages of semaglutide for 31.3 billion rubles, according to DSM Group estimates. This is 71% and 53% more year on year. The picture is similar for Tirazeptid, analogs of Mongero: in nine months, sales reached 49.2 billion rubles. But revenue growth shrank from a hundredfold a year in the first quarter to ninefold in the third quarter. At the same time, the competition is increasing: to the leaders - Geropharm and Promode - Tanek Pharm and PSK Pharma were added in 2026. Pharmacy chains expect a slowdown in cash sales of such products as early as 2027. Russian Federation Telegram | maximum | strain |.

Growth in sales of slimming drugs in Russia has slowed: in the third quarter, pharmacy sales of semaglutide increased by 38% compared to a year, and tripled in 2025, - "Kommersant" In January-September 2026, pharmacies sold 6.3 million packages of semaglutide for 31.3 billion rubles, according to DSM Group estimates. This is 71% and 53% more year on year. The picture is similar for Tirazeptid, analogs of Mongero: in nine months, sales reached 49.2 billion rubles. But revenue growth shrank from a hundredfold a year in the first quarter to ninefold in the third quarter. At the same time, the competition is increasing: to the leaders - Geropharm and Promode - Tanek Pharm and PSK Pharma were added in 2026. Pharmacy chains expect a slowdown in cash sales of such products as early as 2027. Russian Federation Telegram | maximum | strain |.